NeuroBo Pharmaceuticals Inc (NRBO)
2.40
+0.05
(+2.13%)
USD |
NASDAQ |
Nov 22, 16:00
2.40
0.00 (0.00%)
After-Hours: 16:52
NeuroBo Pharmaceuticals Shareholders Equity (Quarterly): 12.95M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.95M |
| June 30, 2024 | 18.94M |
| March 31, 2024 | 10.08M |
| December 31, 2023 | 16.68M |
| September 30, 2023 | 21.55M |
| June 30, 2023 | 25.20M |
| March 31, 2023 | 20.51M |
| December 31, 2022 | 21.75M |
| September 30, 2022 | 5.938M |
| June 30, 2022 | 8.833M |
| March 31, 2022 | 11.93M |
| December 31, 2021 | 14.60M |
| September 30, 2021 | 6.125M |
| June 30, 2021 | 9.478M |
| March 31, 2021 | 13.15M |
| December 31, 2020 | 7.203M |
| September 30, 2020 | 9.506M |
| June 30, 2020 | 12.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.74M |
| December 31, 2019 | 12.29M |
| September 30, 2019 | -1.025M |
| June 30, 2019 | 1.964M |
| March 31, 2019 | 4.446M |
| December 31, 2018 | -13.29M |
| September 30, 2018 | 10.85M |
| June 30, 2018 | 15.05M |
| March 31, 2018 | 20.82M |
| December 31, 2017 | 3.941M |
| September 30, 2017 | 9.949M |
| June 30, 2017 | 17.73M |
| March 31, 2017 | 25.30M |
| December 31, 2016 | 20.63M |
| September 30, 2016 | 26.99M |
| June 30, 2016 | -15.96M |
| March 31, 2016 | -0.594M |
| December 31, 2015 | -12.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.938M
Minimum
Sep 2022
25.20M
Maximum
Jun 2023
13.34M
Average
12.32M
Median
Shareholders Equity (Quarterly) Benchmarks
| Dermata Therapeutics Inc | 4.741M |
| Cognition Therapeutics Inc | 14.48M |
| ZyVersa Therapeutics Inc | 7.027M |
| Cytokinetics Inc | -13.91M |
| Ocugen Inc | 40.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.15M |
| Total Liabilities (Quarterly) | 9.193M |